Statement Of Cash Flows

Perseus Proteomics Inc. - Filing #7246108

Concept As at
2023-03-31
2022-04-01 to
2023-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2021-03-31
Statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-562,409,000 JPY
-474,968,000 JPY
Income taxes paid
-1,927,000 JPY
-1,927,000 JPY
Net cash provided by (used in) operating activities
-564,274,000 JPY
-476,842,000 JPY
Cash flows from operating activities
Cash flows from operating activities
Cash flows from facilities maintenance and investing activities
Purchase of property, plant and equipment
-163,870,000 JPY
-33,868,000 JPY
Cash flows from investing activities
Net cash provided by (used in) investing activities
-212,989,000 JPY
-33,868,000 JPY
Cash flows from financing activities
Proceeds from issuance of shares
JPY
2,623,975,000 JPY
Purchase of treasury shares
-20,000 JPY
JPY
Net cash provided by (used in) financing activities
-20,000 JPY
2,647,548,000 JPY
Other, net
JPY
-4,868,000 JPY
Net increase (decrease) in cash and cash equivalents
-769,918,000 JPY
2,145,552,000 JPY
Effect of exchange rate change on cash and cash equivalents
7,365,000 JPY
8,714,000 JPY
Cash and cash equivalents
2,444,934,000 JPY
3,214,852,000 JPY
1,069,300,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.